From 2013 to 2017, the population of US patients prescribed treatment for chronic hepatitis C virus (HCV) changed, becoming predominantly treatment-naïve and having received care in nonacademic centers.
Steven L. Flamm, MD
Advertisement
Articles by Steven L. Flamm, MD
Advertisement
Latest Updated Articles
- Considerations for the Cost-Effective Management of Hepatic Encephalopathy
Published: March 1st 2018 | Updated:
- Changing Demographics Among Populations Prescribed HCV Treatment, 2013-2017
Published: July 12th 2019 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
2
US, Japan Patients With Diabetes Discontinue Semaglutide After First Year
3
Childhood Insurance Dynamics Predict Medicaid Cuts Will Widen Gaps
4
How Health Systems, Pharmacy Teams Tackle Rare Disease Therapy Barriers: David Mitchell, PharmD, MBA
5
